Predictive value of high-sensitivity C-reactive protein in patients with idiopathic dilated cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue SUPPL. 1, 2005, Pages

  Lamparter, Steffen ^a   Grimm, Wolfram ^a,b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Arrhythmic risk; High sensitivity C reactive protein; Idiopathic dilated cardiomyopathy; Sudden death

Indexed keywords

C REACTIVE PROTEIN;

ADULT; BLOOD LEVEL; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; STATISTICAL ANALYSIS; SUDDEN DEATH;

ARRHYTHMIA; C-REACTIVE PROTEIN; CARDIOMYOPATHY, DILATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 12844268666     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.00034.x     Document Type: Conference Paper

References (11)

1. Grimm W. Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: What have we learned and what can we expect from future trials? Card Electrophysiol Rev 2003; 7:463-467.
2. Grimm W, Christ M, Bach J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy - Results of the Marburg Cardiomyopathy Study. Circulation 2003; 108:2883-2891.
3. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557-1565.
4. Blake GJ, Rifai N, Buring JE, et al. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003; 108:2993-2999.
5. Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study. Circulation 2003; 107:1486-1491.
6. Speidl WS, Graf S, Hornykewycz S, et al. High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am Heart J 2002; 144:449-455.
7. Burke AP, Tracy RP, Kolodgie F, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies. Circulation 2002; 105:2019-2023.
8. Yin WH, Chen JW, Jen HL, et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 2004; 147:931-938.
9. Kaneko K, Kanda T, Yamauchi Y, et al. C-Reactive protein in dilated cardiomyopathy. Cardiology 1999; 91:215-219.
10. Kushner I, Sehgal AR. Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk? Arch Intern Med 2002; 162:867-869.
11. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidomiological applications. Clin Chem 1997; 43:52-58.